Setting eyes on new heights: CDRD announces first-ever cohort of their Executive Institute

by • September 6, 2018 • Business Focus, Feature Slider, Feature-Home, Featured-Slides-Home, UncategorizedComments Off on Setting eyes on new heights: CDRD announces first-ever cohort of their Executive Institute560

The Centre for Drug Research and Development, Canada’s national life sciences venture, announces the first cohort of the CDRD Academy’s Executive Institute.

Earlier this year, CDRD and Pfizer Canada announced the launch of the Executive Institute under the umbrella of The CDRD Academy. The Institute is a 10-month, focused executive development program open to a limited number of senior-level life sciences professionals annually. It was made possible by a $1M contribution by Pfizer Canada.

After reviewing dozens of applications from across Canada, the Adjudication Committee has selected a cohort of diverse, talented, and forward-thinking individuals that is gender balanced, and represents a variety of personal and professional backgrounds. The following individuals have been accepted into the inaugural 2018-2019 class:

  • Naveed Aziz, Chief Administrative and Scientific Officer, CGEN – Canada’s Genomic Enterprise, Toronto, ON
  • Deanna Dryhurst, Chief Scientific Officer, ImmunoPrecise Antibodies Ltd., Victoria, BC
  • Alexander Graves, Chief Executive Officer, Symvivo Corporation, Vancouver, BC
  • Allison Gaw, Senior Director, Corporate Development and Intellectual Property, Sierra Oncology, Vancouver, BC
  • Nataša Jovic, Senior Director, Personal Health, Microbiome Insights, Vancouver, BC
  • Andrew Knowles, Senior Vice President, Operations, STEMCELL Technologies, Vancouver, BC
  • Frédéric Leduc, Chief Executive Officer and Co-Founder, Immune Biosolutions, Sherbrooke, QC
  • Stephanie Michaud, President and Chief Executive Officer, BioCanRx, Ottawa, ON
  • Carolyn Nalder, Director of Business Operations, Tevosol, Edmonton, AB
  • Frederic Ors, Chief Executive Officer, IMV, Quebec City, QC
  • Chris Sinclair, Vice President, Global Commercial Operations, Emergent BioSolutions, Winnipeg, MB
  • Kimberly Stephens, Chief Financial Officer, Appili Therapeutics Inc., Halifax, NS
  • Carol Stiff, Senior Director, Sales and Marketing, Santen Canada, Toronto, ON
  • Jefferson Tea, Vice President, Medical and Scientific Affairs, Takeda Canada Inc., Oakville, ON.

“The core of any business is people and supporting and growing our pool of highly-qualified personnel is critical to drive Canada’s health sciences sector,” says Gordon C. McCauley, president and CEO of CDRD. “Through the CDRD Academy’s Post-Graduate and Undergraduate Institutes, we have seen tremendous success over the past 10 years in helping high-potential scientists be more commercially minded. But, with the addition of the Executive Institute to the CDRD Academy, we are now extending our work to also help high-potential business people lead Canada’s science-based businesses of tomorrow; and ensure Canada has the management talent it needs to lead the life sciences world.”

The CDRD Executive Institute program is delivered in collaboration with the not-for-profit Center for Creative Leadership (CCL). The program has been custom-designed and aims to combine researched and proven best practices/principles with targeted industry topics to take participants on a leadership journey. It will blend in-depth assessments, workshops, simulations, challenging assignments and executive coaching.

‘’The CDRD Executive Institute is off to a very strong start,’’ says John Helou, president, Pfizer Canada. ‘’This first cohort of life science executives exemplifies the type of leaders needed for the industry to reach its full potential. We are pleased to help meet the development needs expressed by life sciences industry stakeholders across the country, and to be able to count on the leadership of CDRD to implement concrete measures that will increase the innovative skill level of this vital industry. We are confident that the tailored training and coaching will contribute to the success of many life science organizations in Canada, which is critical for the development of new treatments for unmet medical needs’’.

Bruce Ralston, British Columbia’s Minister of Jobs, Trade and Technology goes on to say, “The Centre for Drug Research and Development is helping develop the highest level of executive talent to ensure that Canadian life sciences companies have the support they need to advance the sector. This training program is crucial to creating a new generation of leaders that will continue to innovate and produce critically important work that helps improve people’s lives.”

This course offers a unique opportunity that will further the life sciences community within Canada and potentially bring the sector and consequently, the economy to new heights. The first face-to-face session will happen in Vancouver September 12-13, 2018, with additional workshops to be held in Montreal and Toronto throughout the Winter and Spring 2019.

Comments are closed.